Clinical Trial: Palbociclib and Pembrolizumab in Undifferentiated Pleomorphic Sarcoma (UPS)
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Undifferentiated Pleomorphic Sarcoma
Study Type: INTERVENTIONAL
Official Title: Phase Ib Trial Evaluating the Combination of CDK4 Inhibitor With Immunotherapy in Patients With Undifferentiated Pleomorphic Sarcoma (UPS)
Brief Summary:
This is a single-arm open-label window of opportunity clinical study assessing the impact of pre- treatment with palbociclib
Read more